Litcius/Paper detail

Differential expression of tau species and the association with cognitive decline and synaptic loss in Alzheimer's disease

Sivaprakasam R. Saroja, Abhijeet Sharma, Patrick R. Hof, Ana C. Pereira

2021Alzheimer s & Dementia48 citationsDOIOpen Access PDF

Abstract

Pathological tau proteins in patients with Alzheimer's disease (AD) mainly accumulate in the form of neurofibrillary tangles (NFTs) and neuritic plaques (NPs). However, the molecular properties of tau species present in NFTs and NPs are not known. We tested the hypothesis that tau species within NFT-predominant tissue (NFT_AD) are distinct and more toxic than those in NP-predominant tissue (NP_AD). We analyzed the tau species from post mortem prefrontal cortical brains of NFT_AD and NP_AD. Compared to NP_AD, NFT_AD displayed highly phosphorylated tau oligomers, possessed tau oligomers in extracellular vesicles, and the 3-repeat (3R) and 4-repeat (4R) isoforms were differentially expressed between the groups. Comparison of tau proteins isolated from NFT- versus NP-AD subjects demonstrated higher tau seeding activity in NFT subjects and a greater degree of inducing synaptic loss in cultured neurons. We propose that tau species from NFT-predominant tissues possess greater levels of degenerative properties, thereby causing synaptic loss and cognitive decline.

Topics & Concepts

Senile plaquesCognitive declineAlzheimer's diseaseNeuroscienceTau proteinPathologicalGene isoformExtracellularSynaptic vesicleBiologyChemistryDiseaseCell biologyBiochemistryPathologyDementiaMedicineVesicleGeneMembraneAlzheimer's disease research and treatmentsNeuroscience and Neuropharmacology ResearchMemory and Neural Mechanisms
Differential expression of tau species and the association with cognitive decline and synaptic loss in Alzheimer's disease | Litcius